New York to receive nearly $3 million for breast cancer research

New York to receive nearly $3 million for breast cancer research

September 12, 2018 11:47 AM

Governor Andrew Cuomo announced Wednesday that nearly $3 million in funding will be awarded to breast cancer research projects across New York.

The grants will provide research into the causes of breast cancer, prevention, detection or screening, treatment along with new educational strategies.


"New York will continue to take action and make investments that help advance breast cancer research, raise public awareness, and ensure access to early detection and prevention services," Governor Cuomo said. "Breast cancer affects thousands of people across this state and in order to provide New Yorkers with the best care, these investments will support the brilliant minds studying, teaching and researching at our colleges, universities and medical schools." 

The awardees of the grant include:

Peter T. Rowley Breast Cancer Scientific Research Projects 
•    Albert Einstein College of Medicine, Cristina Montagna, PhD - $360,000 
•    Stony Brook University, Jun Lin, MD, PhD - $360,000 
•    University at Buffalo, Jo Feudenheim, PhD - $359,024 
•    Icahn School of Medicine at Mount Sinai, Jose Silva, PhD - $360,000 
•    Albert Einstein College of Medicine, Harry Ostrer, MD - $326,910 
•    Cornell University, Scott Coonrod, PhD - $358,832 
•    University at Albany, Jonathan Petruccelli, PhD - $335,905 
Patricia S. Brown Breast Cancer Risk Reduction Education Research Projects 
•    Hunter College CUNY, Jin Young Seo, PhD - $245,002 
•    Icahn School of Medicine at Mount Sinai, Lina Jandorf, MA - $268,599 

Breast cancer is the most commonly diagnosed cancer and the second leading cause of cancer death among women in New York State. 

Each year, over 15,000 women in New York State are newly diagnosed with breast cancer, and approximately 2,500 die from the disease. 


Copyright 2018 - WHEC-TV, LLC A Hubbard Broadcasting Company

Relay Media Amp

We no longer have Facebook comments on this site. Please visit our Facebook Page to join the conversation.